Salas Eduardo Rene

Salas Eduardo Rene is listed in filings as Director at ADMA Biologics, Inc.. This profile follows SEC Form 4 activity through Feb 11, 2026, including 14 public disclosures. Recent filings connect the profile to ADMA Biologics, Inc. (ADMA) and Intra-Cellular Therapies Inc. (ITCI) (ITCI). The current snapshot covers public activity from Jun 18, 2024 to Feb 11, 2026. Reported amounts are shown as $290.2K to $929.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.